Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.

Source:http://linkedlifedata.com/resource/pubmed/id/19543144

Download in:

View as

General Info

PMID
19543144